News
Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...
Vivani Medical and Okava expand GLP-1 therapy research to dogs, aiming to advance long-acting treatments for cardiometabolic ...
One such breakthrough comes from PharmaZee, a leading provider of GLP-1 medication, particularly Semaglutide ... the pricing structure, the benefits, and common FAQs. GLP-1, or glucagon-like ...
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...
Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...
Shares of Eli Lilly (LLY) jumped on Thursday morning after the company announced topline Phase 3 results from ACHIEVE-1, evaluating the safety ...
A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.
Seeking Alpha analyst Stephen Ayers shares his views on which weight-loss drug stock looks most attractive for investors ...
An expert has explained that if you take weight-loss drugs you might get 'Ozempic mouth', though it's not all bad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results